Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We could get approval and AF to write a hit piece about the drug that it would be no good.
It's holding $5.
Yes he talks nothing about science.
Doesn't mean anyone bought also.
Someone sold
Lesson learned at $14. Sell the highs. Hold your gains until trend changes.
Profit never bad. Buy low sell high. How many times have we not held gain. From $14.83 to $3.29 not a great move.
I've learned not to be greedy. 20% on a good number is good for me.
Giving back gains same old
Me too I had regn at $32. What a mistake selling.
The fool are fools.
You could be right why no data yet. Partner then data ?
We will get a partner my guess
Shouldn't this be at the old high $14.83 or higher. Don't we all think more great news to come?
Lets hope
They are trying
Date designated 4/6/2016
The fda report say 4/6/2016, but it came out today.
http://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=512615
Agreed.
Ah but grass hopper say fda likes our drug. Says to me me great info to come and really our market cap compared to axon is way to small. How many will cover short today
Just imagine what data will look like
Will this be our big short covering? Will Missling present data now after close? We bogus law suits go away? Partner? All possible
Granted orphan drug status. Missling firing on all cylinder. Data will be great is my guess
Missling being very careful it looks like. Just after upgrade we get a opinion article not science to bash us. I think he knows once he releases data that same opinion article will appear saying oh we where just a shell company. I hope he has something great up his sleeve. Yes they are deal with symptoms we deal with cause. If our drug helps the cause that's of greater benefit with little side affects. Our would work better because it deals with the cause not symptoms a whole different thing. Bp is scared of little avxl.
Close the $9 gap
Gave back all gains. 2 days.
Funny how chart man show up and down we go I should sold yesterday greed again
Wow that's great
My guess tomorrow they takeout stops at 200 dma then take it higher.
If the drugs working bp will be all over this and avxl pipeline. Billions
Data has alway been trashed by basher article. I hope they have huge announcement.
Only 1000 sh traded. Maybe data is taking longer we here about subpeona about bogus law suit. LL had good result one of its. Maybe partner or buyout. And maybe great data. Maybe taking longer as they know articles like today will happen and they are now going thru better motions to keep price up
Every company has she has authorized any company could reissue new shares. Like you said they did not look at the science or thus could help alzhiemers patients. The drug has little side affects. Anyone could write about what he wrote about write about the science because that's technical and most guys don't have the technical experience. He knows nothing of science. I enjoyed what you wrote.
Mm know greed. Selling the Higgs has been profitable. So far no sustained gain. All gain sold off $14 $8 $6 all bouncing all the low